244 studies found for:    Open Studies | "Hepatitis B"
Show Display Options
Rank Status Study
21 Unknown  Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
Conditions: Chronic Hepatitis B;   Chronic Hepatitis D
Intervention: Drug: pegylated IFN alfa-2b plus ribavirin
22 Unknown  Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Pegasys plus Entecavir;   Drug: Entecavir
23 Recruiting Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: Pegasys&Entecavir
24 Recruiting PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: Peginterferon alfa-2a;   Drug: Nucleos(t)ide analogue
25 Recruiting Safety and Efficacy of GS-9620 for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Subjects
Condition: Chronic Hepatitis B
Interventions: Drug: GS-9620;   Drug: Placebo to match GS-9620
26 Recruiting Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues
Condition: Chronic Hepatitis B
Interventions: Drug: Continue NA treatment;   Drug: Discontinue NA Treatment
27 Not yet recruiting Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis
Condition: Hepatitis B, Chronic
Intervention: Drug: Tenofovir disoproxil fumarate
28 Unknown  Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Biological: HBV DNA vaccine;   Other: Placebo
29 Unknown  Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: PEG-IFN and entecavir
30 Unknown  Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy
Condition: Chronic Hepatitis B
Intervention: Drug: Switching from adefovir (10mg/day) to tenofovir (300mg/day)
31 Not yet recruiting Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study
Condition: Hepatitis B, Chronic
Intervention: Drug: Tenofovir disoproxil fumarate
32 Unknown  A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon
Condition: Chronic Hepatitis B
Intervention: Drug: pegylated Interferon-alpha 2a
33 Recruiting Hepatitis B Booster Study in Adolescence
Condition: Hepatitis B
Intervention:
34 Recruiting Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: Tenofovir disoproxil fumarate;   Drug: Lamivudine plus adefovir
35 Recruiting Hepatitis B Seroepidemiology Among Young Adults
Condition: Hepatitis B
Intervention:
36 Unknown  Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
Conditions: Hepatitis B, Chronic;   Hepatitis C, Chronic
Intervention: Drug: Peginterferon Alfa-2a plus Ribavirin
37 Recruiting Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B
Condition: Hepatitis B
Intervention: Drug: Entecavir and peginterferon
38 Unknown  Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: Tenofovir;   Drug: Telbivudine;   Drug: Tenofovir plus Telbivudine
39 Unknown  Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study
Condition: Chronic Hepatitis B
Interventions: Drug: telbivudine plus adefovir;   Drug: lamivudine plus adefovir
40 Recruiting Randomized,Paralleled-group Clinical Trial of Hepatitis B Vaccine With Different Doses and Schedules in Healthy Adults
Condition: Hepatitis B
Intervention: Biological: Hepatitis B vaccine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years